Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
The Job of a Migration Legal advisor: How They Can Help You - 2Step by step instructions to Choose the Right Auto Crash Legal counselor for Your Case
- 3Whale stranded off Germany for days found stuck again
- 4Mom finds out she has cancer after noticing something was off while breastfeeding
- 5Vote in favor of Your #1 Instructive Toy: Learning and Tomfoolery Joined
- Fire Allegedly Triggered by Wedding Cake Sparkler Causes Venue to Go Up in Flames, Leaving Groom with Second-Degree Burns
- Potential Houthi threat to Red Sea shipping could further damage global economy
- Hezbollah claims right to respond to killing of top commander
- Well known Tea Brands for Each Tea Sweetheart
- Track down the Ideal Weight reduction Methodology for Your Way of life
- Top Breakfast Food: What's Your Morning Enjoyment?
- Vote in favor of your Number one Sort of Cap
- What is a Trump Gold Card? U.S. launches $1 million immigration visas
- Massive supernova explosion may have created a binary black hole
